Last Posted: Nov 20, 2019
- Pharmaco-Geno-Proteo-Metabolomics and Translational Research in Cancer.
Fernández-Figueroa Edith A et al. Advances in experimental medicine and biology 2019 11681-7 - Genetic risk scores to predict the prognosis of chronic heart failure patients in Chinese Han.
Li Shiyang et al. Journal of cellular and molecular medicine 2019 Oct - Deep Learning-Based Multi-Omics Integration Robustly Predicts Survival in Liver Cancer.
Chaudhary Kumardeep et al. Clinical cancer research : an official journal of the American Association for Cancer Research 2018 24(6) 1248-1259 - Diagnostic Biomarkers: Are We Moving from Discovery to Clinical Application?
Parker Lucy A et al. Clinical chemistry 2018 64(11) 1657-1667 - Developing pathways to clarify pathogenicity of unclassified variants in Osteogenesis Imperfecta genetic analysis.
Balasubramanian Meena et al. Molecular genetics & genomic medicine 2019 Sep e912 - [Research progress of feature selection and machine learning methods for mass spectrometry-based protein biomarker discovery].
Xu Kaikun et al. Sheng wu gong cheng xue bao = Chinese journal of biotechnology 2019 Sep 35(9) 1619-1632 - Current omics-based biomarkers for cholangiocarcinoma.
Intuyod Kitti et al. Expert review of molecular diagnostics 2019 Oct 1-9 - Heart Failure in the Era of Precision Medicine: A Scientific Statement From the American Heart Association.
Cresci Sharon et al. Circulation. Genomic and precision medicine 2019 Sep HCG0000000000000058 - The Childhood Cancer Data Initiative: Transforming the Pediatric Cancer Landscape through Sharing Data
DR Lowy, NCI, August 15, 2019 - Quantifying the impact of public omics data.
Perez-Riverol Yasset et al. Nature communications 2019 Aug 10(1) 3512
.png)
No hay comentarios:
Publicar un comentario